Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Double U Master Fund is a specialized investment vehicle managed by Woodline Partners LP, a San Francisco-based alternative asset management firm. The fund focuses on fundamental equity investments within the healthcare and technology sectors, with a significant emphasis on biotechnology and pharmaceutical companies. It employs a research-intensive, bottom-up approach to identify investment opportunities across various sub-sectors, including medical devices and healthcare services. Managed by experienced portfolio managers formerly of Citadel, the fund is a prominent institutional investor in the life sciences space. It operates within a master-feeder structure designed to accommodate institutional capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Double U Master Fund.